主权项 |
1. A method for modulating blood glucose in a subject in need thereof, comprising administering to the subject an effective amount of a compound selected from the following:
(S,E)-2-(3,4-dihydroxyphenyl)-6-(3,7-dimethylocta-2,6-dien-1-yl)-5,7-dihydroxy-3,4-dihydro-2H-1-benzopyran-4-one (PPC) (S,E)-2-(2-(3,7-dimethylocta-2,6-dien-1-yl)-3,4-dihydroxyphenyl)-5,7-dihydroxy-3,4-dihydro-2H-1-benzopyran-4-one (PPD) (S,E)-2-(3-(3,7-dimethylocta-2,6-dien-1-yl)-4,5-dihydroxyphenyl)-5,7-dihydroxy-3,4-dihydro-2H-1-benzopyran-4-one (PPF) (S,E)-2-(2-(3,7-dimethylocta-2,6-dien-1-yl)-3,4-dihydroxyphenyl)-5,5,7-dihydroxy-6-(3-methylbut-2-en-1-yl)-3,4-dihydro-2H-1-benzopyran-4-one (PPG) (S)-2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-6-((2E,6E)-3,7,11-trimethyldodeca-2,6,10-trien-1-yl)-3,4-dihydro-2H-1-benzopyran-4-one (PPI) (S,E)-2-(3,4-dihydroxy-2-(7-hydroxy-3,7-dimethyloct-2-en-1-yl)phenyl)-5,7-dihydroxy-3,4-dihydro-2H-1-benzopyran-4-one (PPA) 10 (S,E)-2-(3,4-dihydroxy-5-(7-hydroxy-3,7-dimethyloct-2-en-1-yl)phenyl)-5,7-dihydroxy-3,4-dihydro-2H-1-benzopyran-4-one (PPB) (S,E)-2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-6-(7-hydroxy-3,7-dimethyloct-2-en-1-yl)-3,4-dihydro-2H-1-benzopyran-4-one (Pokinawan) (S,E)-2-(3,4-dihydroxy-2-(7-hydroxy-3,7-dimethyloct-2-en-1-yl)phenyl)-5 5,7-dihydroxy-6-(3-hydroxy-3-methylbutyl)-3,4-dihydro-2H-1-benzopyran-4-oneand
(S)-2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-6-((2E,6E)-11-hydroxy-3,7,11-trimethyldodeca-2,6-dien-1-yl)-3,4-dihydro-2H-1-benzopyran-4-one |